Startup TeselaGen Biotechnology is preparing to launch a cloud-based commercial version of the j5 software package, an automated DNA cloning tool that was developed by a research team at the Joint BioEnergy Institute.

TeselaGen licensed j5 from Lawrence Berkeley National Laboratory, the lead institutional partner of JBEI. The commercial version of the software is currently being tested in an ongoing private beta by several undisclosed industrial and pharmaceutical companies ahead of a full launch slated for early 2013.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

In PLOS this week: oral microbiomes of dogs and their owners, Plasmodium vivax population structure, and more.

The American Society of Human Genetics has issued a position statement on genetic testing of children.

The White House seeks to update how biotechnology products are regulated.

Team science leads some researchers to get lost in the shuffle, the Chronicle of Higher Education reports.